Back to top

Bayer Probes Sevabertinib–Metformin Combo In New Phase 1 Study

Bayer AG ($BAYRY) announced an update on their ongoing clinical study. This Bayer study, titled “Phase 1, Open-label, Fixed-sequence Crossover Stud...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bayer Aktiengesellschaft (BAYRY)